FDA Issues Complete Response Letter for Etripamil for PSVT
Go back to FDA Issues Complete Response Letter for Etripamil for PSVT| (NASDAQ: MIST) | Delayed: 1.26 -0.02 (1.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.28 | 52 Week High | $ | |||
| Open | $1.29 | 52 Week Low | $ | |||
| Day High | $1.29 | P/E | N/A | |||
| Day Low | $1.26 | EPS | $ | |||
| Volume | 38,149 | |||||

